Scientists test new cancer drug duo in hopeful early trial
NCT ID NCT02617277
Summary
This early-stage study aimed to find a safe dose for a new two-drug combination (adavosertib and durvalumab) for patients with advanced solid tumors that had stopped responding to standard treatments. It involved 56 adult patients and tested different dosing schedules to see how much medicine the body could handle and what side effects occurred. The main goal was to understand the safety of this combination before testing if it could help shrink tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOURS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Denver, Colorado, 80218, United States
-
Research Site
Sarasota, Florida, 34232, United States
-
Research Site
Nashville, Tennessee, 37203, United States
Conditions
Explore the condition pages connected to this study.